Instrument Inactif

Communiqués Dechra Pharmaceuticals PLC OTC Markets

Actions

DCHPF

GB0009633180

Communiqués

27/12/23	Form 8.5 (EPT/RI) - Dechra Pharmaceuticals plc	AQ
30/10/23	Dechra Pharmaceuticals : 30 October 2023 Annual Report 2023 (Online)	PU
17/10/23	Dechra Pharmaceuticals : 17 October 2023 Annual Report 2023 ESEF XHTML	PU
17/10/23	Dechra Pharmaceuticals : 17 October 2023 Annual Report 2023	PU
07/09/23	Form 8.3 - Dechra Pharmaceuticals plc	AQ
05/09/23	Form 8.3 - Dechra Pharmaceuticals PLC	AQ
04/09/23	Form 8.5 (EPT/RI) - Dechra Pharmaceuticals plc	AQ
09/08/23	Pentwater Capital Management LP - Form 8.3 - DECHRA PHARMACEUTICALS ORD	PR
09/08/23	HBK Investments LP - Form 8.3 - Dechra Pharmaceuticals Plc	PR
08/08/23	Pentwater Capital Management LP - Form 8.3 - Dechra Pharmaceuticals Plc	PR
08/08/23	HBK Investments LP - Form 8.3 - Dechra Pharmaceuticals Plc	PR
26/06/23	Dechra Pharmaceuticals : Scheme Document - Recommended cah acquisition of Dechra by Freya Bidco Ltd	PU
02/06/23	Ashurst advises on recommended takeover of Dechra Pharmaceuticals plc	AQ
25/04/23	Form 8.3 - AXA INVESTMENT MANAGERS: Dechra Pharmaceuticals plc	AQ
14/04/23	Form 8.3 - AXA INVESTMENT MANAGERS: Dechra Pharmaceuticals plc.	AQ
27/02/23	Dechra Pharmaceuticals : 27 February 2023 Half Yearly Presentation for the Period ended 31 December 2022	PU
28/11/22	Dechra Pharmaceuticals : 28 November 2022 Investor Conference Presentation - November 2022	PU
20/10/22	Dechra Pharmaceuticals : 20 October 2022 Results of 2022 Annual General Meeting	PU
20/09/22	Dechra Pharmaceuticals : 20 September 2022 Shareholder Directive Notice 2022	PU
20/09/22	Dechra Pharmaceuticals : 20 September 2022 Notice of 2022 Annual General Meeting	PU
20/09/22	Dechra Pharmaceuticals : 20 September 2022 Annual Report 2022 (Online)	PU
06/09/22	Dechra Pharmaceuticals : 06 September 2022 Annual Report 2022 ESEF XHTML	PU
05/09/22	Dechra Pharmaceuticals : 05 September 2022 Preliminary Results Presentation for the year ended 30 June 2022	PU
31/08/22	DW Healthcare Partners Announces Sale of Med-Pharmex to Dechra Pharmaceuticals PLC	AQ
21/02/22	Dechra Pharmaceuticals : 21 February 2022 Recording of the Analyst Presentation regarding the Half-Year results for the period ended 31 December 2021	PU